S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
NYSE:CIM

Chimera Investment Stock Forecast, Price & News

$8.82
+0.22 (+2.56 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.60
Now: $8.82
$8.87
50-Day Range
$8.20
MA: $8.66
$9.12
52-Week Range
$6.42
Now: $8.82
$22.99
Volume2.32 million shs
Average Volume4.29 million shs
Market Capitalization$2.05 billion
P/E RatioN/A
Dividend Yield13.95%
Beta0.87
Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency and non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, commercial mortgage loans, and other real estate related securities. It has elected to be taxed as a real estate investment trust. As a result, the company would not be subject to U.S. federal income tax, if it distributes at least 90% of its REIT taxable income to its shareholders. Chimera Investment Corporation was founded in 2007 and is headquartered in New York, New York.
Read More
Chimera Investment logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.1Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.70 out of 5 stars

Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryMortgage REITs
SectorFinance
CUSIP16934Q10
Phone212-626-2300
Employees39

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.36 billion
Cash Flow$2.93 per share
Book Value$21.12 per share

Profitability

Net Income$413.55 million

Miscellaneous

Market Cap$2.05 billion
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$8.82
+0.22 (+2.56 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CIM News and Ratings via Email

Sign-up to receive the latest news and ratings for CIM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chimera Investment (NYSE:CIM) Frequently Asked Questions

How has Chimera Investment's stock been impacted by COVID-19 (Coronavirus)?

Chimera Investment's stock was trading at $18.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CIM stock has decreased by 52.0% and is now trading at $8.82.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Chimera Investment?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chimera Investment
.

When is Chimera Investment's next earnings date?

Chimera Investment is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Chimera Investment
.

How can I listen to Chimera Investment's earnings call?

Chimera Investment will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Chimera Investment's earnings last quarter?

Chimera Investment Co. (NYSE:CIM) released its earnings results on Wednesday, August, 5th. The real estate investment trust reported $0.32 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.01. Chimera Investment had a positive return on equity of 11.88% and a negative net margin of 17.05%. During the same period in the previous year, the firm earned $0.53 earnings per share.
View Chimera Investment's earnings history
.

How often does Chimera Investment pay dividends? What is the dividend yield for Chimera Investment?

Chimera Investment declared a quarterly dividend on Tuesday, September 15th. Investors of record on Tuesday, September 29th will be paid a dividend of $0.30 per share on Thursday, October 29th. This represents a $1.20 annualized dividend and a dividend yield of 13.61%. The ex-dividend date is Monday, September 28th.
View Chimera Investment's dividend history
.

What price target have analysts set for CIM?

4 brokers have issued twelve-month price objectives for Chimera Investment's shares. Their forecasts range from $9.00 to $12.00. On average, they expect Chimera Investment's stock price to reach $10.33 in the next twelve months. This suggests a possible upside of 17.2% from the stock's current price.
View analysts' price targets for Chimera Investment
.

Who are some of Chimera Investment's key competitors?

What other stocks do shareholders of Chimera Investment own?

Who are Chimera Investment's key executives?

Chimera Investment's management team includes the following people:
  • Mr. Matthew J. Lambiase, Pres, CEO & Director (Age 54, Pay $6.53M)
  • Mr. Robert Colligan CPA, Chief Financial Officer (Age 49, Pay $2.64M)
  • Mr. Choudhary Yarlagadda, Chief Operating Officer (Age 58, Pay $4.64M)
  • Mr. Mohit Marria, Chief Investment Officer (Age 42, Pay $3.99M)
  • Mr. Phillip John Kardis II, Chief Legal Officer & Corp. Sec. (Age 59, Pay $3.95M)

What is Chimera Investment's stock symbol?

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Who are Chimera Investment's major shareholders?

Chimera Investment's stock is owned by a number of retail and institutional investors. Top institutional shareholders include LSV Asset Management (1.15%), Envestnet Asset Management Inc. (0.08%), Pegasus Asset Management Inc. (0.07%), Nisa Investment Advisors LLC (0.06%), Ziegler Capital Management LLC (0.04%) and Avantax Advisory Services Inc. (0.04%). Company insiders that own Chimera Investment stock include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II and Robert S Colligan.
View institutional ownership trends for Chimera Investment
.

Which major investors are selling Chimera Investment stock?

CIM stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, James Investment Research Inc., and Great Valley Advisor Group Inc..
View insider buying and selling activity for Chimera Investment
.

Which major investors are buying Chimera Investment stock?

CIM stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., Pegasus Asset Management Inc., Avantax Advisory Services Inc., Nisa Investment Advisors LLC, Chicago Capital LLC, Clear Street Markets LLC, Concorde Asset Management LLC, and Ziegler Capital Management LLC. Company insiders that have bought Chimera Investment stock in the last two years include Choudhary Yarlagadda, Matthew Lambiase, Paul Donlin, Phillip John Kardis II, and Robert S Colligan.
View insider buying and selling activity for Chimera Investment
.

How do I buy shares of Chimera Investment?

Shares of CIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chimera Investment's stock price today?

One share of CIM stock can currently be purchased for approximately $8.82.

How big of a company is Chimera Investment?

Chimera Investment has a market capitalization of $2.05 billion and generates $1.36 billion in revenue each year. The real estate investment trust earns $413.55 million in net income (profit) each year or $2.25 on an earnings per share basis. Chimera Investment employs 39 workers across the globe.

What is Chimera Investment's official website?

The official website for Chimera Investment is www.chimerareit.com.

How can I contact Chimera Investment?

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The real estate investment trust can be reached via phone at 212-626-2300 or via email at [email protected]

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.